Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 12 jun 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News 11 jan 2023 Bachem Group secures CHF 1 billion peptide supply contract Bachem Group's recent CHF 1 billion peptide supply deal, spanning over five years will enable the company's plans to expand capacity across all i...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 17 mai 2023 Geneva start-ups Fluosphera, Kylys Aesthetics and Consulto receive FIF support The Fondation Genevoise pour l’Innovation Technologique (Fongit) has announced the latest recipients of the Fongit Innovation Fund (FIF) support....
News 22 mar 2023 FIF funding awarded to three innovative Geneva-based projects Geneva-based start-ups Plair, Endotelix, and Dr. Beat Walpoth have received the Fongit Innovation Fund (FIF) for their remarkable innovations.
Инвестиции в Швейцарии Ваши контакты за рубежом Представительства S-GE за рубежом называются «Швейцарские Центры содействия бизнесу» (Swiss Business Hubs).
Investieren in die Schweiz Standortpromotion der Schweiz im Ausland Die Vertretungen von S-GE im Ausland werden als Swiss Business Hubs (SBH) geführt.
Investir na Suíça Promoção de Investimentos Internacionais na Suíça Os escritórios de representação da S-GE no exterior recebem o nome de Swiss Business Hubs (SBH).
Invertir en Suiza Fomento de la inversión en el extranjero Las representaciones de S-GE en el extranjero se denominan Swiss Business Hubs (SBH).
Investir en Suisse Promotion des investissements en Suisse depuis l'étranger Les représentations de S-GE à l’étranger sont structurées en Swiss Business Hubs (SBH).
Press Release 15 dez 2022 Swiss technology for digital worlds For the fifth time in a row, Switzerland is taking part in the Consumer Electronics Show (CES) in Las Vegas. Under the motto "swisstech for exten...